SCN2A oligonucleotide antisense therapy (Real Regulatory)

N/A

Report date: 2025/03/20 15:21:27
NME

Base Information

Drug NameSCN2A oligonucleotide antisense therapy (Real Regulatory)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionSodium channel protein type II alpha subunit blockers
TargetsSodium channel protein type II alpha subunit
Therapy Area/IndicationsBrain Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesReal Regulatory Ltd
China Registration ClassN/A

Develop Information

Active CompaniesReal Regulatory Ltd
Inactive CompaniesN/A
Active IndicationsBrain Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A